The development of information channels for improving the processes of monitoring and analyzing information on the safety of medicinal products is an important critical process of pharmacovigilance and the duty of the authorized person for pharmacovigilance (FDA) at the manufacturer of medicinal products. As part of the effective implementation of this routine process in the [...]
Krasheninnikov A.E., Matveev A.V. Autonomous non-profit organization "National Scientific Center of Pharmacovigilance", 127051, Russia, Moscow, st. Malaya Sukharevskaya, pl. d. 2, p. 2. It is known that the use of drugs in modern clinical practice is accompanied by the risk of side effects, the cause of which, in many cases, is the level of drug [...]
R.S. Safiullin, A.E. Krasheninnikov In various national systems of the global global pharmacovigilance architecture, pharmaceutical workers have traditionally been one of the leading links in the collection and upstream channel of information on adverse events associated with drug use. The organization of pharmacovigilance determines the procedure for collecting spontaneous reactions about adverse drug events, as [...]
Abstract Among the diseases of the cardiovascular system, arterial hypertension due to the significant prevalence of the disease, a high risk of complications and low patient compliance takes a special place. One of the most important factors playing a role in the pathogenesis of hypertension is the activation of the renin-angiotensin-aldosterone system. Angiotensin-converting enzyme inhibitors [...]
